PRVA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for PRVA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, PRVA is valued expensive at the moment.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year PRVA was profitable.
In the past year PRVA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: PRVA reported negative net income in multiple years.
In the past 5 years PRVA always reported a positive cash flow from operatings.

1.2 Ratios

PRVA's Return On Assets of 1.34% is in line compared to the rest of the industry. PRVA outperforms 52.94% of its industry peers.
PRVA's Return On Equity of 2.56% is in line compared to the rest of the industry. PRVA outperforms 56.86% of its industry peers.
With a Return On Invested Capital value of 2.45%, PRVA perfoms like the industry average, outperforming 48.04% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	1.34%
ROE	2.56%
ROIC	2.45%

ROA(3y)0.83%

ROA(5y)-3.09%

ROE(3y)1.55%

ROE(5y)-3.63%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin of PRVA (0.89%) is comparable to the rest of the industry.
PRVA's Profit Margin has declined in the last couple of years.
PRVA has a Operating Margin (1.38%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PRVA has declined.
PRVA has a Gross Margin of 10.17%. This is in the lower half of the industry: PRVA underperforms 73.53% of its industry peers.
PRVA's Gross Margin has improved in the last couple of years.

		Industry Rank	Sector Rank
OM	1.38%
PM (TTM)	0.89%
GM	10.17%

OM growth 3YN/A

OM growth 5Y-13.74%

PM growth 3YN/A

PM growth 5Y-4.5%

GM growth 3Y15.6%

GM growth 5Y3.18%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

PRVA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, PRVA has more shares outstanding
The number of shares outstanding for PRVA has been increased compared to 5 years ago.
There is no outstanding debt for PRVA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

PRVA has an Altman-Z score of 4.42. This indicates that PRVA is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.42, PRVA is in the better half of the industry, outperforming 78.43% of the companies in the same industry.
PRVA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0
Altman-Z	4.42

ROIC/WACC0.28

WACC8.91%

2.3 Liquidity

PRVA has a Current Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.67, PRVA is doing good in the industry, outperforming 63.73% of the companies in the same industry.
PRVA has a Quick Ratio of 1.67. This is a normal value and indicates that PRVA is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PRVA (1.67) is better than 68.63% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.67
Quick Ratio	1.67

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 30.00% over the past year.
Measured over the past 5 years, PRVA shows a small growth in Earnings Per Share. The EPS has been growing by 7.43% on average per year.
The Revenue has grown by 19.01% in the past year. This is quite good.
Measured over the past years, PRVA shows a quite strong growth in Revenue. The Revenue has been growing by 17.17% on average per year.

EPS 1Y (TTM)30%

EPS 3YN/A

EPS 5Y7.43%

EPS Q2Q%66.67%

Revenue 1Y (TTM)19.01%

Revenue growth 3Y21.58%

Revenue growth 5Y17.17%

Sales Q2Q%27.1%

3.2 Future

PRVA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.05% yearly.
PRVA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.73% yearly.

EPS Next Y22%

EPS Next 2Y70.67%

EPS Next 3Y69.05%

EPS Next 5YN/A

Revenue Next Year-27.71%

Revenue Next 2Y-9.32%

Revenue Next 3Y-3.84%

Revenue Next 5Y2.73%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 178.62 indicates a quite expensive valuation of PRVA.
The rest of the industry has a similar Price/Earnings ratio as PRVA.
PRVA is valuated expensively when we compare the Price/Earnings ratio to 28.32, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 72.47, PRVA can be considered very expensive at the moment.
PRVA's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of PRVA to the average of the S&P500 Index (25.57), we can say PRVA is valued expensively.

		Industry Rank	Sector Rank
PE	178.62
Fwd PE	72.47

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PRVA is valued a bit more expensive than 61.76% of the companies in the same industry.
PRVA's Price/Free Cash Flow is on the same level as the industry average.

		Industry Rank	Sector Rank
P/FCF	25.8
EV/EBITDA	64.76

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PRVA does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as PRVA's earnings are expected to grow with 69.05% in the coming years.